Notable
Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Primary completion pushed from Mar 31, 2026 to Mar 31, 2027
Liping DouPhase 2 NCT07651475 Registry history of NCT07651475 on ClinicalTrials.gov (opens the registry)
3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.
Primary completion pushed from Mar 31, 2026 to Mar 31, 2027
Liping DouPhase 2 NCT07651475 Registry history of NCT07651475 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Liping DouEarly Phase 1 NCT07586709 Registry history of NCT07586709 on ClinicalTrials.gov (opens the registry)
Start date pushed from Sep 30, 2026 to Oct 1, 2026
Liping DouPhase 1 NCT07841002 Registry history of NCT07841002 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-25 | NCT07841002 CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid… | Phase 1 | Not Yet Recruiting |
| Early Phase 1 | 1 | |
| Phase 1 | 2 | |
| Phase 1/2 | 3 | |
| Phase 2 | 3 |
Leukemia (6) · Acute Lymphoblastic Leukemia (ALL) (3) · Acute Myeloid Leukemia (AML) (3) · Myelodysplastic Syndromes (MDS) (1)